Can LAAM, like Lazarus, come back from the dead?

Addiction

Volumn 102, Issue 9, 2007, Pages 1342-1343

  Jaffe, Jerome H ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; LEVACETYLMETHADOL; METHADONE;

DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG MARKETING; DRUG METABOLISM; DRUG OVERDOSE; EDITORIAL; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FOOD AND DRUG ADMINISTRATION; HEART VENTRICLE TACHYCARDIA; HEROIN DEPENDENCE; HUMAN; PATIENT CARE; QT PROLONGATION; RISK ASSESSMENT; RISK FACTOR; TORSADE DES POINTES; TREATMENT FAILURE;

ARRHYTHMIAS, CARDIAC; HEROIN DEPENDENCE; HUMANS; METHADYL ACETATE;

EID: 34547829539     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01976.x     Document Type: Editorial

References (12)

1. FDA letter to Roxane Laboratories. Available at: http://www.fda.gov/cder/ foi/appletter/2001/20315S6LTR.PDF (accessed 24 June 2007).
2. Anglin M. D., Conner B. T., Annon J., Longshore D. Levo-alpha- acetylmethadol (LAAM) versus methadone maintenance. One-year treatment retention, outcomes, and status. Addiction 2007 102 : 1432 42.
3. Clark N., Lintzeris N., Gijsbers A., Whelan G., Dunlop A., Ritter A., Ling W. LAAM maintenance vs methadone maintenance for heroin dependence. Cochrane Database Syst Rev 2002 2 : CD002210.
4. Ritter A., Lintzeris N., Clark N., Jozica J., Kutin J. J., Bammer G. et al. A randomized trial comparing levo-alpha-acetylmethadol with methadone maintenance for patients in primary care settings in Australia. Addiction 2003 98 : 1605 13.
5. Ling W., Charuvastra V. C., Kaim S. C., Klett C. J. Methadyl acetate and methadone as maintenance treatments for opiate addicts. Arch Gen Psychiatry 1976 33 : 709 20.
6. Marsch L. A., Stephens M. A. C., Mudric T., Strain E. C., Bigelow G. E., Johnson R. E. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol 2005 13 : 293 302.
7. Pearson E. C., Woosley R. L. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005 14 : 747 53.
8. Justo D., Gal-Ox A., Paran Y., Goldin Y., Zeltser D. Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients. Addiction 2006 101 : 1333 8.
9. Krantz M. J., Lewkowiez L., Hays H., Woddroffe M. A., Robertson A. D., Mehler P. S. Torsade de Pointes associated with very-high-dose methadone. Ann Intern Med 2002 137 : 501 4.
10. Newcombe D. A., Bochner F., White J. M., Somogyi A. A. Evaluation of levo-alpha-acetylmethadol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis. Drug Alcohol Depend 2004 76 : 63 72.
11. Mattick R. P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2004 3 : CD002207.
12. Schottenfeld R. S., Chawarski M. C., Pakes J. R., Pantalon M. V., Carroll K. M., Kosten T. R. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry 2005 162 : 340 9.